KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Current Leases: 2012-2025

Historic Current Leases for Novavax (NVAX) over the last 6 years, with Sep 2025 value amounting to $5.0 million.

  • Novavax's Current Leases fell 47.95% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year decrease of 47.95%. This contributed to the annual value of $7.0 million for FY2024, which is 75.07% down from last year.
  • According to the latest figures from Q3 2025, Novavax's Current Leases is $5.0 million, which was down 9.29% from $5.6 million recorded in Q2 2025.
  • In the past 5 years, Novavax's Current Leases ranged from a high of $161.5 million in Q4 2021 and a low of $953,000 during Q2 2023.
  • For the 3-year period, Novavax's Current Leases averaged around $7.3 million, with its median value being $5.6 million (2025).
  • In the last 5 years, Novavax's Current Leases tumbled by 99.23% in 2023 and then skyrocketed by 889.19% in 2024.
  • Quarterly analysis of 5 years shows Novavax's Current Leases stood at $161.5 million in 2021, then plummeted by 72.72% to $44.1 million in 2022, then slumped by 36.18% to $28.1 million in 2023, then plummeted by 75.07% to $7.0 million in 2024, then crashed by 47.95% to $5.0 million in 2025.
  • Its last three reported values are $5.0 million in Q3 2025, $5.6 million for Q2 2025, and $5.5 million during Q1 2025.